I N Ferrier
Overview
Explore the profile of I N Ferrier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
133
Citations
2673
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Thomas A, Gallagher P, Robinson L, Porter R, Young A, Ferrier I, et al.
Psychol Med
. 2008 Aug;
39(5):725-33.
PMID: 18667097
Background: Neurocognitive impairment is a well-recognized feature of depression that has been reported in younger and older adults. Similar deficits occur with ageing and it is unclear whether the greater...
22.
Anderson I, Ferrier I, Baldwin R, Cowen P, Howard L, Lewis G, et al.
J Psychopharmacol
. 2008 Apr;
22(4):343-96.
PMID: 18413657
A revision of the 2000 British Association for Psychopharmacology evidence-based guidelines for treating depressive disorders with antidepressants was undertaken to incorporate new evidence and to update the recommendations where appropriate....
23.
Gallagher P, Malik N, Newham J, Young A, Ferrier I, Mackin P
Cochrane Database Syst Rev
. 2008 Feb;
(1):CD005168.
PMID: 18254070
Background: Antiglucocorticoids may have antidepressant effects and have been reported to be efficacious in the treatment of severe psychiatric disorders. The efficacy and safety of antiglucocorticoid treatments for mood disorders...
24.
Mackin P, Bishop D, Watkinson H, Ferrier I
J Psychopharmacol
. 2008 Jan;
22(5):563-6.
PMID: 18208918
Anti-psychotic drugs, particularly the second generation, or ;atypical' agents, have been implicated in the development of metabolic dysfunction such as diabetes mellitus. There is a paucity of longitudinal data on...
25.
Thanacoody R, Daly A, Reilly J, Ferrier I, Thomas S
Clin Pharmacol Ther
. 2007 Apr;
82(5):555-65.
PMID: 17460606
The objective of this study was to investigate factors affecting steady-state plasma concentrations of thioridazine. A cross-sectional study of patients receiving chronic thioridazine was employed. Common allelic variants of CYP2D6...
26.
Thomas A, Hendriksen M, Piggott M, Ferrier I, Perry E, Ince P, et al.
Neuropathol Appl Neurobiol
. 2006 Apr;
32(3):296-303.
PMID: 16640648
Previous studies investigating the serotonin transporter (SERT) in depression have been inconsistent and included a large proportion of subjects who had committed suicide. In Alzheimer's disease studies have generally reported...
27.
Watson S, Gallagher P, Hearn A, Ferrier I, Young A
Psychol Med
. 2002 Sep;
32(6):1021-8.
PMID: 12214783
Background: Hypothalamic-pituitary-adrenal (HPA) axis function in patients with chronic depression has previously been shown to be normal when measured using the dexamethasone suppression test (DST). We examined patients with chronic...
28.
Reilly J, Ayis S, Ferrier I, Jones S, Thomas S
Br J Psychiatry
. 2002 Jun;
180:515-22.
PMID: 12042230
Background: Sudden death has been linked to antipsychotic therapy, but the relative risk associated with specific drugs is unknown. Aims: To assess the risk of sudden unexplained death associated with...
29.
Ferrier I
J Clin Psychiatry
. 2002 Jan;
62 Suppl 26:10-5.
PMID: 11775087
A paradigm shift in the management of depression has transpired in recent years with the modification of treatment goals toward remission, an outcome that transcends response. Pharmacotherapy, psychotherapy, electroconvulsive therapy,...
30.
Ferrier I
Br Med Bull
. 2001 Nov;
57:179-92.
PMID: 11719917
Bipolar affective disorder is a life-long condition with profound effects on sufferers' social and occupational life. Despite efficacy in clinical trials and in some groups of patients, lithium's effectiveness in...